Zydus has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strengths of 0.5 g and 1 g, it said in a regulatory filing. The capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/D5RasBH
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Zydus Lifesciences gets USFDA nod for generic medication
https://ift.tt/6vLfFQY
No comments:
Post a Comment